Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-22-000129

President and CEO sold 4,768 shares at $1.85 ($8,810)

  • President and CEO acquired 10,937 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Brunn Carsten President and CEO 2022-09-01 Option exercise +10,937 545,327 D
Brunn Carsten President and CEO 2022-09-02 Sale −4,768 $1.85 $8,810 540,559 D
Derivatives
Brunn Carsten President and CEO 2022-09-01 Option exercise · Restricted Stock Units −10,937 10,938 D
Open-market sales · 4,768 sh · avg $1.85 · $8,810
Loading xslF345X03/wf-form4_166251104851877.xml…